BOD Australia Ltd - Bod continues to achieve upward trajectory in medicinal cannabis prescriptions
BOD Australia Ltd (ASX:BDA)

Bod continues to achieve upward trajectory in medicinal cannabis prescriptions

Document   View Announcement
Published May 20, 2020

What happened?

What's happened?

Bod Australia Ltd (ASX: BDA, “Bod”) has advised that it is continuing to experience significant uptake of its MediCabilis™ product amongst Australian patients.

What are the key highlights?

  1. During April 2020, Bod filled 516 prescriptions, marking a 35% increase on March 2020 (March prescriptions: 382) and the Company’s third largest volume month on record.
  2. The large volumes generated in April leave Bod well positioned to exceed Q3 MediCabilis™ prescriptions, which totalled 1,099.
  3. Bod has now filled a total of 3,459 prescriptions in FY2020, which has added significantly to the Company’s growing revenue profile.
  4. Repeat prescriptions for April accounted for 60% of the month’s total volume. The amount of repeat prescriptions achieved each month is increasing and the Company is confident this will continue as volumes grow.

file

For further details, please read the announcement linked below.

CEO's summary

Jo Patterson CEO of BOD Australia Ltd has provided a statement.
Jo Patterson
Jo Patterson
CEO, BOD Australia Ltd

"Achieving 516 MediCabilis™ prescriptions and a strong repeat purchase rate in April is a great result for Bod and we are pleased with the steady increase in sales. Following our recent market entry into the United Kingdom and through our participation in Project Twenty21, we anticipate that prescription volumes will continue to rise. The increase in volumes and the Company’s recent expansion into the UK leave Bod well positioned to potentially deliver its largest volume quarter of medicinal cannabis sales ever. We continue to enjoy strong demand for our MediCabilis™ product range amongst patients in Australia and the United Kingdom and I look forward to updating shareholders on ongoing product uptake across the coming months. "

Question   Ask Jo Patterson a question...

Download Announcement

View this announcement as well as our full profile on the company.
Document   View Announcement
View BDA's Full Profile Arrow Forward

Comments

Share your thoughts about this announcement...
Similar articles
Bod continues to achieve strong revenue growth in FY2020
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) advises that it has achieved strong revenue growth in recent months...
3 years ago
First medical cannabis prescriptions received from UK patients participating in Project Twenty21
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has confirmed first prescriptions of the Company’s MediCabilis™ med...
3 years ago
Record additional $1.43m binding purchase order to further strengthen FY2020 revenue
What's happened? Bod Australia Ltd (ASX: BDA, “Bod”) has received a binding purchase order from Health & Happiness G...
3 years ago
Around the web
Why these ASX firms are shying away from the pot stock label – Part Two
Neurotech says due to often negative publicity around cannabis companies it tends not to promote it...
via stockhead.com.au
Clinical results for ancient therapy help ASX cannabis stocks weed out competition
Several ASX companies are undergoing rigorous clinical trials to gain regulatory approval for their...
via stockhead.com.au
Weed Week: Decriminalising cannabis could save Aussie tax payers billions every year
Penington Institute says pot-related law enforcement costs us $1.7 billion a year   Local cannabis...
via stockhead.com.au
Powered by  
  • Company
    BOD Australia Ltd
  • Website
  • Sector
    Distributors
  • Industry
    Distributors
  • Code
    ASX:BDA
  • Socials
View BOD Australia Ltd's Profile

How do I invest?

Considering investing in BOD Australia Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:BDA

    On your online investment platform search for the stock ticker code ASX:BDA to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.

Trade for $9.50 Arrow Forward
Up